OFIX Fundamental Analysis - ORTHOFIX MEDICAL INC

Fundamental Rating

OFIX gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 187 industry peers in the Health Care Equipment & Supplies industry. OFIX scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. While showing a medium growth rate, OFIX is valued expensive at the moment.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year OFIX was profitable.

OFIX had a positive operating cash flow in the past year.

OFIX had negative earnings in 4 of the past 5 years.

In multiple years OFIX reported negative operating cash flow during the last 5 years.

1.2 Ratios

OFIX's Return On Assets of -14.78% is in line compared to the rest of the industry. OFIX outperforms 54.55% of its industry peers.

The Return On Equity of OFIX (-26.99%) is comparable to the rest of the industry.

		Industry Rank	Sector Rank
ROA	-14.78%
ROE	-26.99%
ROIC	N/A

ROA(3y)-11.59%

ROA(5y)-8.47%

ROE(3y)-18.73%

ROE(5y)-13.37%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

With a decent Gross Margin value of 67.37%, OFIX is doing good in the industry, outperforming 73.26% of the companies in the same industry.

OFIX's Gross Margin has declined in the last couple of years.

The Profit Margin and Operating Margin are not available for OFIX so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	67.37%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-3.19%

GM growth 5Y-2.65%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

OFIX does not have a ROIC to compare to the WACC, probably because it is not profitable.

Compared to 1 year ago, OFIX has more shares outstanding

OFIX has more shares outstanding than it did 5 years ago.

OFIX has a worse debt/assets ratio than last year.

2.2 Solvency

Based on the Altman-Z score of 1.19, we must say that OFIX is in the distress zone and has some risk of bankruptcy.

OFIX's Altman-Z score of 1.19 is in line compared to the rest of the industry. OFIX outperforms 53.48% of its industry peers.

The Debt to FCF ratio of OFIX is 380.24, which is on the high side as it means it would take OFIX, 380.24 years of fcf income to pay off all of its debts.

OFIX's Debt to FCF ratio of 380.24 is fine compared to the rest of the industry. OFIX outperforms 64.71% of its industry peers.

OFIX has a Debt/Equity ratio of 0.38. This is a healthy value indicating a solid balance between debt and equity.

OFIX has a Debt to Equity ratio (0.38) which is in line with its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0.38
Debt/FCF	380.24
Altman-Z	1.19

ROIC/WACCN/A

WACC7.81%

2.3 Liquidity

OFIX has a Current Ratio of 2.67. This indicates that OFIX is financially healthy and has no problem in meeting its short term obligations.

OFIX's Current ratio of 2.67 is in line compared to the rest of the industry. OFIX outperforms 52.41% of its industry peers.

OFIX has a Quick Ratio of 1.50. This is a normal value and indicates that OFIX is financially healthy and should not expect problems in meeting its short term obligations.

OFIX has a Quick ratio (1.50) which is in line with its industry peers.

		Industry Rank	Sector Rank
Current Ratio	2.67
Quick Ratio	1.5

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

OFIX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 1300.00%, which is quite impressive.

OFIX shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -63.14% yearly.

OFIX shows a small growth in Revenue. In the last year, the Revenue has grown by 4.84%.

OFIX shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 11.69% yearly.

EPS 1Y (TTM)1300%

EPS 3Y-77.34%

EPS 5Y-63.14%

EPS Q2Q%160%

Revenue 1Y (TTM)4.84%

Revenue growth 3Y19.84%

Revenue growth 5Y11.69%

Sales Q2Q%2.27%

3.2 Future

OFIX is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -356.00% yearly.

The Revenue is expected to grow by 4.93% on average over the next years.

EPS Next Y-24427%

EPS Next 2Y-1104.39%

EPS Next 3Y-356%

EPS Next 5YN/A

Revenue Next Year2.05%

Revenue Next 2Y3.58%

Revenue Next 3Y4.93%

Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 97.79, the valuation of OFIX can be described as expensive.

OFIX's Price/Earnings ratio is a bit cheaper when compared to the industry. OFIX is cheaper than 63.64% of the companies in the same industry.

Compared to an average S&P500 Price/Earnings ratio of 26.41, OFIX is valued quite expensively.

The Forward Price/Earnings Ratio is negative for OFIX. No positive earnings are expected for the next year.

		Industry Rank	Sector Rank
PE	97.79
Fwd PE	N/A

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, OFIX is valued a bit cheaper than the industry average as 65.24% of the companies are valued more expensively.

		Industry Rank	Sector Rank
P/FCF	1163.5
EV/EBITDA	N/A

4.3 Compensation for Growth

OFIX's earnings are expected to decrease with -356.00% in the coming years. This may justify a cheaper valuation.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y-1104.39%

EPS Next 3Y-356%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for OFIX!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

ORTHOFIX MEDICAL INC

NASDAQ:OFIX (8/12/2025, 2:12:56 PM)

13.69

+0.75 (+5.8%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupHealth Care Equipment & Services

GICS IndustryHealth Care Equipment & Supplies

Earnings (Last)08-05 2025-08-05/bmo

Earnings (Next)11-05 2025-11-05/amc

Inst Owners87.73%

Inst Owner Change-3.74%

Ins Owners1.66%

Ins Owner Change10.11%

Market Cap536.37M

Analysts83.64

Price Target21.08 (53.98%)

Short Float %6.49%

Short Ratio5.97

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)2

Avg EPS beat(2)103.1%

Min EPS beat(2)80.19%

Max EPS beat(2)126.01%

EPS beat(4)4

Avg EPS beat(4)122.79%

Min EPS beat(4)80.19%

Max EPS beat(4)145.75%

EPS beat(8)8

Avg EPS beat(8)117.11%

EPS beat(12)12

Avg EPS beat(12)100.94%

EPS beat(16)13

Avg EPS beat(16)66.75%

Revenue beat(2)1

Avg Revenue beat(2)0.24%

Min Revenue beat(2)-0.65%

Max Revenue beat(2)1.14%

Revenue beat(4)1

Avg Revenue beat(4)-0.51%

Min Revenue beat(4)-1.92%

Max Revenue beat(4)1.14%

Revenue beat(8)3

Avg Revenue beat(8)-0.52%

Revenue beat(12)4

Avg Revenue beat(12)-1.82%

Revenue beat(16)4

Avg Revenue beat(16)-1.78%

PT rev (1m)-15.3%

PT rev (3m)-14.95%

EPS NQ rev (1m)0%

EPS NQ rev (3m)-4800%

EPS NY rev (1m)0%

EPS NY rev (3m)-1763.99%

Revenue NQ rev (1m)0%

Revenue NQ rev (3m)-3.59%

Revenue NY rev (1m)0%

Revenue NY rev (3m)-0.66%

Valuation

		Industry Rank	Sector Rank
PE	97.79
Fwd PE	N/A
P/S	0.66
P/FCF	1163.5
P/OCF	18.72
P/B	1.17
P/tB	2.91
EV/EBITDA	N/A

EPS(TTM)0.14

EY1.02%

EPS(NY)-1.43

Fwd EYN/A

FCF(TTM)0.01

FCFY0.09%

OCF(TTM)0.73

OCFY5.34%

SpS20.65

BVpS11.7

TBVpS4.71

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-14.78%
ROE	-26.99%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	67.37%
FCFM	0.06%

ROA(3y)-11.59%

ROA(5y)-8.47%

ROE(3y)-18.73%

ROE(5y)-13.37%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-3.19%

GM growth 5Y-2.65%

F-Score5

Asset Turnover0.97

Health

		Industry Rank	Sector Rank
Debt/Equity	0.38
Debt/FCF	380.24
Debt/EBITDA	N/A
Cap/Depr	34.18%
Cap/Sales	3.48%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	2.67
Quick Ratio	1.5
Altman-Z	1.19

F-Score5

WACC7.81%

ROIC/WACCN/A

Cap/Depr(3y)86.5%

Cap/Depr(5y)81.89%

Cap/Sales(3y)6%

Cap/Sales(5y)5.69%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)1300%

EPS 3Y-77.34%

EPS 5Y-63.14%

EPS Q2Q%160%

EPS Next Y-24427%

EPS Next 2Y-1104.39%

EPS Next 3Y-356%

EPS Next 5YN/A

Revenue 1Y (TTM)4.84%

Revenue growth 3Y19.84%

Revenue growth 5Y11.69%

Sales Q2Q%2.27%

Revenue Next Year2.05%

Revenue Next 2Y3.58%

Revenue Next 3Y4.93%

Revenue Next 5YN/A

EBIT growth 1Y1.46%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year202.08%

EBIT Next 3Y51.57%

EBIT Next 5YN/A

FCF growth 1Y100.61%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y174.61%

OCF growth 3Y11.71%

OCF growth 5Y-4.22%

ORTHOFIX MEDICAL INC (OFIX) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens